Background After traumatic brain injury (TBI), plasma concentration of glial fibrillary acidic
protein (GFAP) correlates with intracranial injury visible on CT scan. Some patients with …

Reliable diagnosis of traumatic brain injury (TBI) is a major public health need. Glial fibrillary
acidic protein (GFAP) is expressed in the central nervous system, and breakdown products …

Objective: Identification and validation of blood-based biomarkers for the diagnosis and
prognosis of mild traumatic brain injury (mTBI) is of critical importance. There have been …

Background: This study aimed to determine whether glial fibrillary acidic protein (GFAP) is
released after traumatic brain injury (TBI), whether GFAP is related to brain injury severity …

Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific
proteins released into serum as part of the pathophysiological response after traumatic brain …

Objectives To determine whether a panel of blood-based biomarkers can discriminate
between patients with suspected mild traumatic brain injury (mTBI) with and without …

Background: Glial fibrillary acidic protein (GFAP) is an intermediate filament protein found in
the cytoskeleton of astroglia. Recent work has indicated that GFAP may serve as a serum …

Background: Serum glial fibrillary acidic protein (GFAP) is a specific predictor of brain
damage and neurologic outcome in patients with traumatic brain injury (TBI). In this study …

Background More than 50 million people worldwide sustain a traumatic brain injury (TBI)
annually. Detection of intracranial injuries relies on head CT, which is overused and …

Importance Glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-
L1) have been widely studied and show promise for clinical usefulness in suspected …